Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 3 1Phase 1/2 1

Status

Completed 6Unknown 5Terminated 5Not yet recruiting 2Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Neoplasm Metastasis 2Esophageal Neoplasms 2Stomach Neoplasms 1Patients With Advanced or Metastatic Solid Tumors 1Pancreatic Neoplasms 1Neoplasms, Unknown Primary 1Hand-Foot Syndrome 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Bile Duct Neoplasms 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Cyclophosphamide 1499Cisplatin 1434Paclitaxel 1339Radiotherapy 1310Carboplatin 1266Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 697Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × tegafur-gimeracil-oteracil × Clear all
NCT01845337 2023-05-12

TOFFEE

University of Edinburgh

Phase 2 Completed
59 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms

NCT02564367 2021-04-29

S-1 adjuvant

AIO-Studien-gGmbH

Phase 1/2 Completed
30 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT02128243 2021-03-26

MATEO

AIO-Studien-gGmbH

Phase 2 Completed
242 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Neoplasm Metastasis, Stomach Neoplasms

NCT02347904 2019-11-18

SOX

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1 Completed
40 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01918852 2018-03-14

SALTO

Dutch Colorectal Cancer Group

Phase 3 Completed
161 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms, Hand-Foot Syndrome

NCT02867397 2016-08-15

Study of Teysuno (S-1) Combined With Epirubicin and Oxaliplatin in Patients With Advanced Solid Tumors

Disphar International B.V.

Phase 1 Completed
25 enrolled
Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡